Cargando…

Correction to: Anti-tumor effects of Atractylenolide I on bladder cancer cells

Detalles Bibliográficos
Autores principales:	Yu, Rui, Yu, Bi-xia, Chen, Jun-feng, Lv, Xiu-yi, Yan, Ze-jun, Cheng, Yue, Ma, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190566/ https://www.ncbi.nlm.nih.gov/pubmed/30322391 http://dx.doi.org/10.1186/s13046-018-0913-1

Ejemplares similares

Anti-tumor effects of Atractylenolide I on bladder cancer cells
por: Yu, Rui, et al.
Publicado: (2016)

Anti-Tumor Effects of Atractylenolide-I on Human Ovarian Cancer Cells
por: Long, Fangyi, et al.
Publicado: (2017)

Anti-Tumor Activity of Atractylenolide I in Human Colon Adenocarcinoma In Vitro
por: Chan, Ka Woon Karen, et al.
Publicado: (2020)

UPLC-MS/MS of Atractylenolide I, Atractylenolide II, Atractylenolide III, and Atractyloside A in Rat Plasma after Oral Administration of Raw and Wheat Bran-Processed Atractylodis Rhizoma
por: Xu, Shizhao, et al.
Publicado: (2018)

Anti-Tumor Effects of Atractylenolide I Isolated from Atractylodes macrocephala in Human Lung Carcinoma Cell Lines
por: Liu, Huanyi, et al.
Publicado: (2013)

A Randomized Pilot Study of Atractylenolide I on Gastric Cancer Cachexia Patients
por: Liu, Yi, et al.
Publicado: (2008)

Atractylenolide I inhibits antibiotic-induced dysbiosis of the intestinal microbiome
por: Liu, Penglin, et al.
Publicado: (2021)

Atractylenolide-I Sensitizes Human Ovarian Cancer Cells to Paclitaxel by Blocking Activation of TLR4/MyD88-dependent Pathway
por: Huang, Jian-Ming, et al.
Publicado: (2014)

Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson’s Disease
por: More, Sandeep, et al.
Publicado: (2017)

Monoclonal antibody Zt/g4 targeting RON receptor tyrosine kinase enhances chemosensitivity of bladder cancer cells to Epirubicin by promoting G1/S arrest and apoptosis
por: Chen, Jun-Feng, et al.
Publicado: (2017)

Atractylenolide III ameliorates spinal cord injury in rats by modulating microglial/macrophage polarization
por: Xue, Meng‐Tong, et al.
Publicado: (2022)

Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation
por: Wang, Meng, et al.
Publicado: (2021)

Atractylenolide I alleviates ischemia/reperfusion injury by preserving mitochondrial function and inhibiting caspase-3 activity
por: Sun, Caiqin, et al.
Publicado: (2021)

Chemical Constitution, Pharmacological Effects and the Underlying Mechanism of Atractylenolides: A Review
por: Xie, Zhiyi, et al.
Publicado: (2023)

P2X7 receptor involved in antitumor activity of atractylenolide I in human cervical cancer cells
por: Han, Yue, et al.
Publicado: (2022)

Establishment of a mouse model of cancer cachexia with spleen deficiency syndrome and the effects of atractylenolide I
por: Zhang, Wan-li, et al.
Publicado: (2019)

The Anticancer Effects of Atractylenolide III Associate With the Downregulation of Jak3/Stat3-Dependent IDO Expression
por: Liu, Jun-bao, et al.
Publicado: (2020)

Atractylenolide-I covalently binds to CYP11B2, selectively inhibits aldosterone synthesis, and improves hyperaldosteronism
por: Liu, Wenjuan, et al.
Publicado: (2022)

Atractylenolide-1 alleviates gastroparesis in diabetic rats by activating the stem cell factor/c-kit signaling pathway
por: Li, Hui, et al.
Publicado: (2021)

Correction to: CXCL9 secreted by tumor-associated dendritic cells up-regulates PD-L1 expression in bladder cancer cells by activating the CXCR3 signaling
por: Xiu, Weigang, et al.
Publicado: (2021)

Atractylenolide I Induces Apoptosis and Suppresses Glycolysis by Blocking the JAK2/STAT3 Signaling Pathway in Colorectal Cancer Cells
por: Li, Yanxi, et al.
Publicado: (2020)

Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL‐6 and tumour‐derived extracellular vesicles
por: Fan, Meng, et al.
Publicado: (2022)

Atractylenolide I inhibits EMT and enhances the antitumor effect of cabozantinib in prostate cancer via targeting Hsp27
por: Qiao, Pengfei, et al.
Publicado: (2023)

Author Correction: Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma
por: Zhu, Yongxia, et al.
Publicado: (2022)

Atractylenolide I Ameliorates Acetaminophen-Induced Acute Liver Injury via the TLR4/MAPKs/NF-κB Signaling Pathways
por: Du, Zhongyan, et al.
Publicado: (2022)

Atractylenolide I Inhibits NLRP3 Inflammasome Activation in Colitis-Associated Colorectal Cancer via Suppressing Drp1-Mediated Mitochondrial Fission
por: Qin, Yao, et al.
Publicado: (2021)

Correction: Adverse Events of Anti-Tumor Necrosis Factor α Therapy in Ankylosing Spondylitis
por: Tong, Qiang, et al.
Publicado: (2015)

Correction: Tumor-associated macrophages promote tumor metastasis via the TGF-β/SOX9 axis in non-small cell lung cancer
por: Zhang, Shuai, et al.
Publicado: (2020)

Atractylenolide III Attenuates Angiogenesis in Gastric Precancerous Lesions Through the Downregulation of Delta-Like Ligand 4
por: Gao, Ying, et al.
Publicado: (2022)

Correction: Human Umbilical Mesenchymal Stem Cells-Seeded Bladder Acellular Matrix Grafts for Reconstruction of Bladder Defects in a Canine Model
por: Yuan, Haichao, et al.
Publicado: (2013)

Correction: Improved anti-tumor efficacy via combination of oxaliplatin and fibrin glue in colorectal cancer
por: Hu, Yuzhu, et al.
Publicado: (2020)

Chemopreventive effects of atractylenolide II on mammary tumorigenesis via activating Nrf2-ARE pathway
por: Wang, Ting, et al.
Publicado: (2017)

Catalytic approach to in vivo metabolism of atractylenolide III using biomimetic iron–porphyrin complexes
por: Lim, Hanae, et al.
Publicado: (2021)

Correction to: Novel Functionalized Selenium Nanoparticles for Enhanced Anti-Hepatocarcinoma Activity In vitro
por: Xia, Yu, et al.
Publicado: (2022)

Correction: Enhanced Performance of Brain Tumor Classification via Tumor Region Augmentation and Partition
por: Cheng, Jun, et al.
Publicado: (2015)

Atractylenolide II Inhibits Proliferation, Motility and Induces Apoptosis in Human Gastric Carcinoma Cell Lines HGC-27 and AGS
por: Tian, Shuang, et al.
Publicado: (2017)

Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
por: Li, Heng, et al.
Publicado: (2022)

Correction: The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors
por: Wang, Guosong, et al.
Publicado: (2023)

Correction: Mechanisms Underlying the Anti-Tumoral Effects of Citrus bergamia Juice
por: Delle Monache, Simona, et al.
Publicado: (2018)

Correction: Induction of PGRN by influenza virus inhibits the antiviral immune responses through downregulation of type I interferons signaling
por: Wei, Fanhua, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6khl82ami1ntttqkuo2hcbq05u